1. Home
  2. PCVX vs KBR Comparison

PCVX vs KBR Comparison

Compare PCVX & KBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCVX
  • KBR
  • Stock Information
  • Founded
  • PCVX 2013
  • KBR 1901
  • Country
  • PCVX United States
  • KBR United States
  • Employees
  • PCVX N/A
  • KBR N/A
  • Industry
  • PCVX Biotechnology: Pharmaceutical Preparations
  • KBR Military/Government/Technical
  • Sector
  • PCVX Health Care
  • KBR Industrials
  • Exchange
  • PCVX Nasdaq
  • KBR Nasdaq
  • Market Cap
  • PCVX 4.4B
  • KBR 6.3B
  • IPO Year
  • PCVX 2020
  • KBR 2006
  • Fundamental
  • Price
  • PCVX $33.25
  • KBR $47.62
  • Analyst Decision
  • PCVX Strong Buy
  • KBR Buy
  • Analyst Count
  • PCVX 10
  • KBR 7
  • Target Price
  • PCVX $136.50
  • KBR $64.33
  • AVG Volume (30 Days)
  • PCVX 1.5M
  • KBR 1.5M
  • Earning Date
  • PCVX 08-05-2025
  • KBR 07-31-2025
  • Dividend Yield
  • PCVX N/A
  • KBR 1.39%
  • EPS Growth
  • PCVX N/A
  • KBR N/A
  • EPS
  • PCVX N/A
  • KBR 2.98
  • Revenue
  • PCVX N/A
  • KBR $7,979,000,000.00
  • Revenue This Year
  • PCVX N/A
  • KBR $14.27
  • Revenue Next Year
  • PCVX N/A
  • KBR $8.57
  • P/E Ratio
  • PCVX N/A
  • KBR $15.99
  • Revenue Growth
  • PCVX N/A
  • KBR 12.84
  • 52 Week Low
  • PCVX $27.66
  • KBR $43.89
  • 52 Week High
  • PCVX $121.06
  • KBR $72.60
  • Technical
  • Relative Strength Index (RSI)
  • PCVX 45.61
  • KBR 33.92
  • Support Level
  • PCVX $32.00
  • KBR $46.54
  • Resistance Level
  • PCVX $34.63
  • KBR $48.62
  • Average True Range (ATR)
  • PCVX 1.33
  • KBR 1.26
  • MACD
  • PCVX -0.06
  • KBR -0.30
  • Stochastic Oscillator
  • PCVX 33.67
  • KBR 13.78

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

About KBR KBR Inc.

KBR, formerly Kellogg Brown & Root, is global provider of technology, integrated engineering, procurement, and construction delivery, and operations and maintenance services. The company's business is organized into two segments: government solutions and sustainable technology solutions. KBR has operations in over 30 countries and employs approximately 34,000 people. The firm generated $7.7 billion in revenue in 2024.

Share on Social Networks: